DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

LinksClose Window

References

Fralick M, Schneeweiss S, Patorno E.
Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor.

N Engl J Med 2017;
376: 2300-2303

Download Bibliographical Data

Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.